DOMOXIN
UNII 5C0K1GQB2L
Substance Identification & Data
This profile provides standardized clinical and technical data for Domoxin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5C0K1GQB2L.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 61-74-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
5C0K1GQB2L
61-74-5
N/A
Detailed Substance Profile
Preferred Name
DOMOXIN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C16H18N2O2 International Chemical Identifier digital signature for unique molecular identification.
SMILES String
IXTXYSAWZICAPV-UHFFFAOYSA-N Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
1685
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
N(N)(Cc1ccccc1)CC2Oc3c(OC2)cccc3
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Domoxin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
DOMOXIN
Common Names & Synonyms
DOMOXIN [INN]
Systematic Nomenclature
1-(1,4-BENZODIOXAN-2-YLMETHYL)-1-BENZYLHYDRAZINE
HYDRAZINE, 1-(1,4-BENZODIOXAN-2-YLMETHYL)-1-BENZYL-
Technical Codes
IS 2596